The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

Here is some care advice that should help. Long-acting allergy medicines (such as Zyrtec) are best for nasal allergies. No prescription is needed. Age limit: 6 months and older. Zyrtec dosing for 6 ...

Total symptom scores, nasal obstruction, and doctor and patient perception of improvement were measured as markers of disease severity. Results: Although not statistically significant, both ...